TABLE 1.
Variable | Major Depressive Disorder (N = 194) Mean (SD)/ %Within Group (freq) |
Anxiety Disordersa (N = 53) Mean (SD)/ % Within Group (freq) |
Alcohol Abuseb (N = 92) Mean (SD)/ % Within Group (freq) |
Comorbid Anxietya and Depressive Disorders (N = 192) Mean (SD)/ % Within Group (freq) |
Comorbid Anxietya Depressive Disorders and Alcohol Abuseb (N = 63) Mean (SD)/ % Within Group (freq) |
No Psychiatric Disorder (N = (831) Mean (SD)/ % Within Group (freq) |
Total (N = 1,425) Mean (SD )/% (freq) |
---|---|---|---|---|---|---|---|
Age (years)* | 54.5 (11.3)1 | 50.8 (12.0)1,2 | 53.4 (11.0)1,2 | 51.3 (11.5)2 | 51.0 (11.1)2 | 54.1 (10.7)1 | 53.4(11.0) |
Gender* | |||||||
Male | 51.0 (99) | 28.3 (15) | 70.7 (65) | 32.3 (62) | 54.0 (34) | 53.0 (443) | 50.4 (718) |
Female | 49.0 (95)1 | 71.7 (38)2 | 29.3 (27)3 | 67.7 (130)2 | 46.0 (29)1 | 46.7 (388)1 | 49.6 (707) |
Race/Ethnicity | |||||||
African American, non-Hispanic | 11.3 (22) | 7.6 (4) | 5.4 (5) | 12.5 (24) | 9.5 (6) | 9.6 (80) | 10.1 (141) |
White, non-Hispanic | 80.4 (156) | 81.1 (43) | 82.5 (75) | 78.7 (151) | 76.2 (48) | 79.9 (664) | 81.2 (1137) |
Hispanic | 4.1 (8) | 5.7 (3) | 3.3 (3) | 4.7 (9) | 6.4 (4) | 4.1 (34) | 4.4 (61) |
Other | 1.6 (3) | 3.8 (2) | 2.2 (2) | 0.5 (1) | 0 (0) | 2.7 (22) | 2.1 (30) |
Unknownc | 2.6 (5) | 1.9 (1) | 7.6 (7) | 3.7 (7) | 7.9 (5) | 3.7 (31) | 2.3 (32) |
Referring Clinic | |||||||
Breast | 13.9 (27) | 22.6 (12) | 11.0 (10) | 17.7 (34) | 9.5 (6) | 12.9 (107) | 13.4 (196) |
Dermatology | 2.1 (4) | 3.8 (2) | 3.3 (3) | 2.6 (5) | 9.5 (6) | 5.1 (42) | 4.4 (62) |
Gastrointestinal | 7.2 (14) | 3.8 (2) | 5.4 (5) | 5.2 (10) | 3.2 (2) | 6.6 (55) | 6.0 (85) |
Genitourinary | 9.8 (19) | 9.4 (5) | 14.1 (13) | 13.0 (25) | 7.9 (5) | 13.0 (108) | 12.3 (175) |
Head and neck | 20.1 (39) | 17.0 (9) | 22.8 (21) | 17.2 (33) | 30.2 (19) | 18.7 (155) | 19.4 (276) |
Hematology | 10.3 (20) | 7.6 (4) | 4.4 (4) | 9.4 (18) | 9.5 (6) | 9.6 (80) | 9.3 (132) |
Thoracic | 17.0 (33) | 13.2 (7) | 14.1 (13) | 15.1 (29) | 15.9 (10) | 13.0 (108) | 14.1 (200) |
Cancer prevention | 8.8 (17) | 11.3 (6) | 18.5 (17) | 5.7 (11) | 14.3 (9) | 11.9 (99) | 9.6 (137) |
Otherd | 10.8 (21) | 11.3 (6) | 6.5 (6) | 14.1 (27) | 0 (0) | 9.3 (77) | 11.2 (159) |
Smoking rate (cigarettes/day) | 20.8 (12.6) | 18.6 (15.0) | 21.6 (12.7) | 20.4 (12.1) | 20.7 (14.0) | 18.8 (11.7) | 19.0 (12.5) |
FTNDe score* | 5.4, (2.0)1 | 5.2 (2.5)1,2 | 5.0 (2.3)1,2 | 5.3 (2.1)1 | 5.1 (2.7)1,2 | 4.7 (2.2)2 | 4.9 (2.2) |
Smoking Cessation Medication | |||||||
No medication | 10.8 (21) | 9.4 (5) | 10.9 (10) | 13.0 (25) | 11.1 (7) | 13.2 (110) | 12.5 (178) |
Bupropion | 5.7 (11) | 5.7 (3) | 1.1 (1) | 4.2 (8) | 3.2 (2) | 4.0 (33) | 4.1 (585) |
Varenicline | 41.2 (80) | 39.6 (21) | 44.6 (41) | 33.9 (65) | 39.7 (25) | 42.5 (353) | 41.1 (585) |
Nicotine replacement | 14.4 (28) | 13.2 (7) | 15.2 (14) | 14.1 (27) | 17.5 (11) | 16.6 (138) | 15.8 (225) |
Combination treatment | 27.8 (54) | 32.1 (17) | 28.3 (26) | 34.9 (67) | 28.6 (18) | 23.7 (197) | 26.6 (379) |
Counseling Sessions | 8.4 (6.3) | 9.2 (6.9) | 8.3 (5.1) | 8.3 (6.8) | 7.6 (6.3) | 8.2 (5.6) | 8.2 (6.0) |
Note.
Includes panic and other anxiety disorders.
Probable alcohol abuse/dependence.
Patients had the option of not answering the question about race.
Referring clinics with less than 2% of total.
FTND = Fagerstrom Test for Nicotine Dependence. Means in the same row that do not share numeric subscripts differ at p < .05 on Tukey’s Studentized Range Test for age and FTND and chi–square for sex.
p < .01.